{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:03:05Z","timestamp":1794016985519,"version":"4.8.0"},"reference-count":243,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Austrian Cardiologic Society","award":["FWF P-33874 B"],"award-info":[{"award-number":["FWF P-33874 B"]}]},{"name":"Austrian Science Fund","award":["FWF P-33874 B"],"award-info":[{"award-number":["FWF P-33874 B"]}],"id":[{"id":"https:\/\/ror.org\/013tf3c58","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Austrian Diabetes Association","award":["FWF P-33874 B"],"award-info":[{"award-number":["FWF P-33874 B"]}],"id":[{"id":"https:\/\/ror.org\/00wa5ga86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 million people have suffered from COVID-19 worldwide, and roughly 7 million death cases were attributed to COVID-19. Recent evidence suggests an interplay between COVID-19 and cardiovascular disease (CVD). COVID-19 may serve as a yet underappreciated CVD risk modifier, including risk factors such as diabetes mellitus or arterial hypertension. In addition, recent data suggest that previous COVID-19 may increase the risk for many entities of CVD to an extent similarly observed for traditional cardiovascular (CV) risk factors. Furthermore, increased CVD incidence and worse clinical outcomes in individuals with preexisting CVD have been observed for myocarditis, acute coronary syndrome, heart failure (HF), thromboembolic complications, and arrhythmias. Direct and indirect mechanisms have been proposed by which COVID-19 may impact CVD and CV risk, including viral entry into CV tissue or by the induction of a massive systemic inflammatory response. In the current review, we provide an overview of the literature reporting an interaction between COVID-19 and CVD, review potential mechanisms underlying this interaction, and discuss preventive and treatment strategies and their interference with CVD that were evaluated since the onset of the COVID-19 pandemic.<\/jats:p>","DOI":"10.3390\/v15020508","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T04:32:58Z","timestamp":1676262778000},"page":"508","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Impact of COVID-19 on Cardiovascular Disease"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6198-888X","authenticated-orcid":false,"given":"Ivan","family":"Vosko","sequence":"first","affiliation":[{"name":"Department of Cardiology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zirlik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Bugger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"key":"ref_1","unstructured":"Johns Hopkins University & Medicine Coronavirus Resource Center (2023, January 29). COVID-19 Dashboard. Available online: https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e24971","DOI":"10.1097\/MD.0000000000024971","article-title":"Comorbidities\u2019 potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis","volume":"100","author":"Cheng","year":"2021","journal-title":"Medicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.hrthm.2020.06.026","article-title":"COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors","volume":"17","author":"Mitrani","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jacc.2022.02.003","article-title":"2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee","volume":"79","author":"Gluckman","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"165878","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41589-021-00924-1","article-title":"Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2","volume":"18","author":"Nguyen","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: Implications for SARS-CoV-2","volume":"19","author":"Kratzel","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_13","unstructured":"World Health Organization (2022, August 11). Tracking SARS-CoV-2 Variants. Available online: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jama.2021.24868","article-title":"Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared with Previous Waves","volume":"327","author":"Maslo","year":"2022","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/M22-0308","article-title":"Comparison of Patients Infected with Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments: A Retrospective Cohort Study","volume":"175","author":"Bouzid","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e069761","DOI":"10.1136\/bmj-2021-069761","article-title":"Clinical severity of, and effectiveness of mRNA vaccines against, COVID-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: Prospective observational study","volume":"376","author":"Lauring","year":"2022","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: A cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1604427","DOI":"10.3389\/ijph.2022.1604427","article-title":"The First 110,593 COVID-19 Patients Hospitalised in Lombardy: A Regionwide Analysis of Case Characteristics, Risk Factors and Clinical Outcomes","volume":"67","author":"Mauer","year":"2022","journal-title":"Int. J. Public Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"154845","DOI":"10.1016\/j.metabol.2021.154845","article-title":"Thromboembolism risk among patients with diabetes\/stress hyperglycemia and COVID-19","volume":"123","author":"Calvisi","year":"2021","journal-title":"Metabolism"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.jinf.2020.03.059","article-title":"Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis","volume":"81","author":"Zuin","year":"2020","journal-title":"J. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e023535","DOI":"10.1161\/JAHA.121.023535","article-title":"Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19","volume":"10","author":"Pan","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(21)00214-9","article-title":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial","volume":"9","author":"Bauer","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e13128","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","article-title":"Metabolic regulation of immune responses","volume":"32","author":"Ganeshan","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41366-021-01016-9","article-title":"The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing","volume":"46","author":"Frasca","year":"2022","journal-title":"Int. J. Obes."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1161\/CIRCULATIONAHA.120.050434","article-title":"Myocardial Injury in Adults Hospitalized with COVID-19","volume":"142","author":"Smilowitz","year":"2020","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","article-title":"Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection","volume":"76","author":"Lala","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","first-page":"100950","article-title":"Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: A meta-analysis of 41,013 hospitalized patients","volume":"40","author":"Ogungbe","year":"2022","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2020.08.069","article-title":"Characterization of Myocardial Injury in Patients with COVID-19","volume":"76","author":"Giustino","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e148980","DOI":"10.1172\/jci.insight.148980","article-title":"Cardiovascular complications of COVID-19","volume":"6","author":"Farshidfar","year":"2021","journal-title":"JCI Insight"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s11739-021-02635-w","article-title":"Myocarditis in COVID-19 patients: Current problems","volume":"16","author":"Mele","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s43044-022-00260-2","article-title":"COVID-19 and myocarditis: A review of literature","volume":"74","author":"Ali","year":"2022","journal-title":"Egypt Heart J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"s0140","DOI":"10.1016\/S0140-6736(20)30912-0","article-title":"Myocarditis in a patient with COVID-19: A cause of raised troponin and ECG changes","volume":"395","author":"Doyen","year":"2020","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s15010-020-01424-5","article-title":"First case of COVID-19 complicated with fulminant myocarditis: A case report and insights","volume":"48","author":"Zeng","year":"2020","journal-title":"Infection"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1093\/eurheartj\/ehaa664","article-title":"Pathological features of COVID-19-associated myocardial injury: A multicentre cardiovascular pathology study","volume":"41","author":"Basso","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.recesp.2020.04.001","article-title":"Fulminant myocarditis due to COVID-19","volume":"73","author":"Sionis","year":"2020","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s10554-020-01943-0","article-title":"Delayed isolated peri-myocarditis in a COVID-19 patient with respiratory symptoms but without lung involvement","volume":"36","author":"Spano","year":"2020","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S2213-2600(21)00085-0","article-title":"Delayed-onset myocarditis following COVID-19","volume":"9","author":"Bajaj","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.056817","article-title":"Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis","volume":"145","author":"Ammirati","year":"2022","journal-title":"Circulation"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Tuvali, O., Tshori, S., Derazne, E., Hannuna, R.R., Afek, A., Haberman, D., Sella, G., and George, J. (2022). The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients-A Large Population-Based Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11082219"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.carrev.2020.08.028","article-title":"Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome","volume":"23","author":"Sawalha","year":"2021","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.12691\/ajmcr-8-9-11","article-title":"A Systematic Review of COVID-19 and Myocarditis","volume":"8","author":"Sutarjono","year":"2020","journal-title":"Am. J. Med. Case Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jcmg.2020.06.003","article-title":"Cardiac Magnetic Resonance Characterization of Myocarditis-Like Acute Cardiac Syndrome in COVID-19","volume":"13","author":"Esposito","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jamacardio.2021.2065","article-title":"Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes with Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry","volume":"6","author":"Daniels","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.121.056208","article-title":"Exercise-Induced Cardiac Troponin Elevations: From Underlying Mechanisms to Clinical Relevance","volume":"144","author":"Aengevaeren","year":"2021","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12968-020-00660-w","article-title":"Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes","volume":"22","author":"Crispi","year":"2020","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of Cardiac Infection with SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases","volume":"5","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/ehf2.12805","article-title":"Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies","volume":"7","author":"Escher","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ejhf.1828","article-title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","volume":"22","author":"Tavazzi","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.120.049465","article-title":"Unexpected Features of Cardiac Pathology in COVID-19 Infection","volume":"142","author":"Fox","year":"2020","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/infdis\/jiaa578","article-title":"Postmortem Findings in Italian Patients with COVID-19: A Descriptive Full Autopsy Study of Cases with and Without Comorbidities","volume":"222","author":"Falasca","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jacc.2020.11.031","article-title":"Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week","volume":"77","author":"Kawakami","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2021.02.035","article-title":"Recent Randomized Trials of Antithrombotic Therapy for Patients with COVID-19: JACC State-of-the-Art Review","volume":"77","author":"Talasaz","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.hrthm.2020.05.001","article-title":"Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management","volume":"17","author":"Siripanthong","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Bugger, H., Gollmer, J., Pregartner, G., Wunsch, G., Berghold, A., Zirlik, A., and von Lewinski, D. (2020). Complications and mortality of cardiovascular emergency admissions during COVID-19 associated restrictive measures. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239801"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"100335","DOI":"10.1016\/j.lanwpc.2021.100335","article-title":"Impact of COVID-19 Pandemic on Hospital Admissions of Acute Coronary Syndrome: A Beijing Inpatient Database Study","volume":"19","author":"He","year":"2022","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/eurheartj\/ehaa314","article-title":"Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: The pandemic response causes cardiac collateral damage","volume":"41","author":"Metzler","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e006631","DOI":"10.1161\/CIRCOUTCOMES.120.006631","article-title":"Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China","volume":"13","author":"Tam","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00392-020-01703-z","article-title":"Impact of COVID-19 outbreak on regional STEMI care in Germany","volume":"109","author":"Scholz","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"593496","DOI":"10.3389\/fcvm.2020.593496","article-title":"COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications","volume":"7","author":"Cameli","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMc2010418","article-title":"Out-of-Hospital Cardiac Arrest during the COVID-19 Outbreak in Italy","volume":"383","author":"Baldi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"ehab724.0658","DOI":"10.1093\/eurheartj\/ehab724.0658","article-title":"Out-of-hospital cardiac arrest in COVID-19 era. A single center experience","volume":"42","author":"Aschieri","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_74","first-page":"101058","article-title":"Hospitalization, major complications and mortality in acute myocardial infarction patients during the COVID-19 era: A systematic review and meta-analysis","volume":"41","author":"Pourasghari","year":"2022","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"100055","DOI":"10.1016\/j.lanepe.2021.100055","article-title":"In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study","volume":"3","author":"Campo","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2352-4642(20)30108-5","article-title":"Delayed access or provision of care in Italy resulting from fear of COVID-19","volume":"4","author":"Lazzerini","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jacc.2020.09.546","article-title":"Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients with STEMI","volume":"76","author":"Verdoia","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2020.10.054","article-title":"International Impact of COVID-19 on the Diagnosis of Heart Disease","volume":"77","author":"Einstein","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/joim.13246","article-title":"Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England","volume":"290","author":"Rashid","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2021.06.926","article-title":"Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry","volume":"332","author":"Debel","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4936571","DOI":"10.1155\/2021\/4936571","article-title":"COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives","volume":"2021","author":"Esposito","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: A position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science","volume":"116","author":"Evans","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ejhf.1925","article-title":"The impact of COVID-19 on heart failure hospitalization and management: Report from a Heart Failure Unit in London during the peak of the pandemic","volume":"22","author":"Bromage","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/ejhf.1986","article-title":"Temporal trends in decompensated heart failure and outcomes during COVID-19: A multisite report from heart failure referral centres in London","volume":"22","author":"Cannata","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ejhf.2044","article-title":"In-hospital care in acute heart failure during the COVID-19 pandemic: Insights from the German-wide Helios hospital network","volume":"22","author":"Konig","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized with COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","article-title":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","volume":"41","author":"Inciardi","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/00015385.2021.1890925","article-title":"Heart failure as a complication of COVID-19 infection: Systematic review and meta-analysis","volume":"77","author":"Zuin","year":"2022","journal-title":"Acta Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.jacc.2020.09.549","article-title":"Prognostic Impact of Prior Heart Failure in Patients Hospitalized with COVID-19","volume":"76","author":"Lee","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/ejhf.2052","article-title":"Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study","volume":"22","author":"Tomasoni","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"713560","DOI":"10.3389\/fcvm.2021.713560","article-title":"COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae","volume":"8","author":"Italia","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","article-title":"Deep Vein Thrombosis in Hospitalized Patients with COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome","volume":"142","author":"Zhang","year":"2020","journal-title":"Circulation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Middeldorp","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"100639","DOI":"10.1016\/j.eclinm.2020.100639","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis","volume":"29","author":"Malas","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"819318","DOI":"10.3389\/fcvm.2021.819318","article-title":"Cumulative Evidence for the Association of Thrombosis and the Prognosis of COVID-19: Systematic Review and Meta-Analysis","volume":"8","author":"Xiao","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41569-021-00665-7","article-title":"Current and novel biomarkers of thrombotic risk in COVID-19: A Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium","volume":"19","author":"Gorog","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/ATVBAHA.120.314872","article-title":"Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients with COVID-19","volume":"40","author":"Berger","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Dettlaff-Pokora, A., and Swierczynski, J. (2021). Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094503"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Cho, J.H., Namazi, A., Shelton, R., Ramireddy, A., Ehdaie, A., Shehata, M., Wang, X., Marban, E., Chugh, S.S., and Cingolani, E. (2020). Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0244533"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hrthm.2021.01.018","article-title":"Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection","volume":"18","author":"Mountantonakis","year":"2021","journal-title":"Heart Rhythm"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1111\/jce.14770","article-title":"Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19","volume":"31","author":"Peltzer","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/joa3.12619","article-title":"New-onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID-19)","volume":"37","author":"Ergun","year":"2021","journal-title":"J. Arrhythm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jacep.2021.02.009","article-title":"Atrial Fibrillation in Patients Hospitalized with COVID-19: Incidence, Predictors, Outcomes, and Comparison to Influenza","volume":"7","author":"Musikantow","year":"2021","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.hroo.2021.03.008","article-title":"Cardiac arrhythmias in patients hospitalized with COVID-19: The ACOVID study","volume":"2","author":"Zareini","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e010666","DOI":"10.1161\/CIRCEP.121.010666","article-title":"New-Onset Atrial Fibrillation in Patients Hospitalized with COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry","volume":"15","author":"Rosenblatt","year":"2022","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10840-021-00992-2","article-title":"Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients","volume":"62","author":"Zuin","year":"2021","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.hrthm.2020.06.016","article-title":"COVID-19 and cardiac arrhythmias","volume":"17","author":"Bhatla","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/clc.23767","article-title":"Ventricular repolarization heterogeneity in patients with COVID-19: Original data, systematic review, and meta-analysis","volume":"45","author":"Mahmoudi","year":"2022","journal-title":"Clin. Cardiol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Wan, E.Y.F., Mathur, S., Zhang, R., Yan, V.K.C., Lai, F.T.T., Chui, C.S.L., Li, X., Wong, C.K.H., Chan, E.W.Y., and Yiu, K.H. (2023). Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: A prospective cohort in UK Biobank. Cardiovasc. Res., cvac195.","DOI":"10.1093\/cvr\/cvac195"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","article-title":"Risks and burdens of incident diabetes in long COVID: A cohort study","volume":"10","author":"Xie","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection","volume":"18","author":"Liu","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1053\/j.gastro.2020.08.044","article-title":"Prevalence, Risk Factors, and Outcomes of Hospitalized Patients with Coronavirus Disease 2019 Presenting as Acute Pancreatitis","volume":"159","author":"Inamdar","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.121.057075","article-title":"Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic","volume":"145","author":"Laffin","year":"2022","journal-title":"Circulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ahj.2021.11.017","article-title":"Trends of blood pressure control in the U.S. during the COVID-19 pandemic","volume":"247","author":"Shah","year":"2022","journal-title":"Am. Heart J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41440-021-00784-1","article-title":"Impact of the COVID-19 pandemic on blood pressure control: A nationwide home blood pressure monitoring study","volume":"45","author":"Feitosa","year":"2022","journal-title":"Hypertens. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/HYPERTENSIONAHA.122.19861","article-title":"Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations","volume":"79","author":"Gotanda","year":"2022","journal-title":"Hypertension"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/00033197211053903","article-title":"Does COVID-19 Cause Hypertension?","volume":"73","author":"Akpek","year":"2022","journal-title":"Angiology"},{"key":"ref_126","unstructured":"National Institute for Health and Care Excellence (2020). COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19, National Institute for Health and Care Excellence (NICE)."},{"key":"ref_127","unstructured":"World Health Organization (2023, January 25). A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. 6 October 2021. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-021-01433-3","article-title":"Long COVID in a prospective cohort of home-isolated patients","volume":"27","author":"Blomberg","year":"2021","journal-title":"Nat. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat. Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Gyongyosi, M., Alcaide, P., Asselbergs, F.W., Brundel, B., Camici, G.G., da Costa Martins, P., Ferdinandy, P., Fontana, M., Girao, H., and Gnecchi, M. (2022). Long COVID and the cardiovascular system\u2014elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial & Pericardial Diseases. Cardiovasc. Res., cvac115.","DOI":"10.1093\/cvr\/cvac115"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1038\/s41467-022-33415-5","article-title":"Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study","volume":"13","author":"Hastie","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jchf.2021.10.002","article-title":"Use of Cardiopulmonary Stress Testing for Patients with Unexplained Dyspnea Post-Coronavirus Disease","volume":"9","author":"Mancini","year":"2021","journal-title":"JACC Heart Fail."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajem.2020.12.060","article-title":"Electrocardiographic manifestations of COVID-19","volume":"41","author":"Long","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e2115959","DOI":"10.1001\/jamanetworkopen.2021.15959","article-title":"Assessment of Prolonged Physiological and Behavioral Changes Associated with COVID-19 Infection","volume":"4","author":"Radin","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/ejhf.2347","article-title":"Recovery of cardiac function following COVID-19\u2014ECHOVID-19: A prospective longitudinal cohort study","volume":"23","author":"Lassen","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.echo.2021.01.020","article-title":"Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study","volume":"34","author":"Moody","year":"2021","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.cmi.2021.06.015","article-title":"Cardiac sequelae after coronavirus disease 2019 recovery: A systematic review","volume":"27","author":"Ramadan","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.echo.2021.08.022","article-title":"Cardiorespiratory Abnormalities in Patients Recovering from Coronavirus Disease 2019","volume":"34","author":"Szekely","year":"2021","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ejhf.2451","article-title":"Myocardial work and vascular dysfunction are partially improved at 12 months after COVID-19 infection","volume":"24","author":"Ikonomidis","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/CIRCULATIONAHA.120.049252","article-title":"COVID-19: Myocardial Injury in Survivors","volume":"142","author":"Knight","year":"2020","journal-title":"Circulation"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41569-021-00631-3","article-title":"Cardiac involvement in the long-term implications of COVID-19","volume":"19","author":"Satterfield","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"968584","DOI":"10.3389\/fcvm.2022.968584","article-title":"Cardiovascular manifestations identified by multi-modality imaging in patients with long COVID","volume":"9","author":"Murata","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41569-022-00697-7","article-title":"Long COVID and cardiovascular disease: A learning health system approach","volume":"19","author":"Mohamed","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Zuin, M., Rigatelli, G., Bilato, C., Porcari, A., Merlo, M., Roncon, L., and Sinagra, G. (2022). One-Year Risk of myocarditis after COVID-19 infection: A systematic review and meta-analysis. Can. J. Cardiol., in press.","DOI":"10.1016\/j.cjca.2022.12.003"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jcmg.2021.04.011","article-title":"Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers","volume":"14","author":"Joy","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1148\/radiol.2021211162","article-title":"Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19","volume":"301","author":"Kravchenko","year":"2021","journal-title":"Radiology"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2\u2014Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against COVID-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.puhe.2021.01.021","article-title":"Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection","volume":"193","year":"2021","journal-title":"Public Health"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2022.12992","article-title":"Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection","volume":"328","author":"Kim","year":"2022","journal-title":"JAMA"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone","year":"2022","journal-title":"Nat. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA Vaccine against COVID-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0140-6736(22)00791-7","article-title":"Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: A cohort study in claims databases","volume":"399","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after COVID-19 Vaccination in a Large Health Care Organization","volume":"385","author":"Witberg","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_160","first-page":"e19240","article-title":"Clinical Presentation and Outcomes of Myocarditis Post mRNA Vaccination: A Meta-Analysis and Systematic Review","volume":"13","author":"Matta","year":"2021","journal-title":"Cureus"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41569-021-00662-w","article-title":"Myocarditis after COVID-19 mRNA vaccination: Clinical observations and potential mechanisms","volume":"19","author":"Heymans","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/cid\/ciab707","article-title":"Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model","volume":"74","author":"Li","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/s41467-022-31401-5","article-title":"Age and sex-specific risks of myocarditis and pericarditis following COVID-19 messenger RNA vaccines","volume":"13","author":"Bertrand","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.15585\/mmwr.mm7035e5","article-title":"Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data\u2014United States, March 2020-January 2021","volume":"70","author":"Boehmer","year":"2021","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_166","unstructured":"(2022, August 03). COVID-NET: COVID-19-Associated Hospitalization Surveillance Network, C.f.D.C.a.P, Available online: https:\/\/gis.cdc.gov\/grasp\/covidnet\/covid19_3.html."},{"key":"ref_167","first-page":"s1473","article-title":"Transmissibility of SARS-CoV-2 among fully vaccinated individuals","volume":"22","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","article-title":"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study","volume":"22","author":"Singanayagam","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.2022.0470","article-title":"Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants","volume":"327","author":"Accorsi","year":"2022","journal-title":"JAMA"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/M21-4502","article-title":"Case Series of Thrombosis with Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021","volume":"175","author":"See","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s11239-021-02626-w","article-title":"A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines","volume":"53","author":"Elberry","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_176","unstructured":"American Society of Hematology (2022). Vaccine-Induced Immune Thrombotic Thrombocytopenia, American Society of Hematology."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., and Ustianowski, A. (2021). Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/hrt.2003.031492","article-title":"Glucocorticoid treatment and cardiovascular disease","volume":"90","author":"Ng","year":"2004","journal-title":"Heart"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinternmed.2009.297","article-title":"Glucocorticoid use and risk of atrial fibrillation or flutter: A population-based, case-control study","volume":"169","author":"Christiansen","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s11739-021-02843-4","article-title":"Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: A multicenter retrospective study","volume":"16","author":"Salinas","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"ehab724.1752","DOI":"10.1093\/eurheartj\/ehab724.1752","article-title":"Glucocorticoids in myocarditis therapy after COVID-19","volume":"42","author":"Kovalenko","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00210-021-02049-7","article-title":"Efficacy of synthetic glucocorticoids in COVID-19 endothelites","volume":"394","author":"Ferrara","year":"2021","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"106053","DOI":"10.1016\/j.phrs.2021.106053","article-title":"Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials","volume":"176","author":"Caiazzo","year":"2022","journal-title":"Pharm. Res."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"REMAP-CAP Investigators, Gordon, A.C., Mouncey, P.R., Al-Beidh, F., Rowan, K.M., Nichol, A.D., Arabi, Y.M., Annane, D., Beane, A., and van Bentum-Puijk, W. (2021). Interleukin-6 Receptor Antagonists in Critically Ill Patients with COVID-19. N. Engl. J. Med., 384, 1491\u20131502.","DOI":"10.1056\/NEJMoa2100433"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet, 397, 1637\u20131645.","DOI":"10.1101\/2021.02.11.21249258"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","article-title":"Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized with COVID-19 Pneumonia: A Randomized Clinical Trial","volume":"181","author":"Salvarani","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_188","first-page":"CD013881","article-title":"Interleukin-6 blocking agents for treating COVID-19: A living systematic review","volume":"3","author":"Ghosn","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Castagne, B., Viprey, M., Martin, J., Schott, A.M., Cucherat, M., and Soubrier, M. (2019). Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220178"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: A double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa188","article-title":"Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: A case report","volume":"4","author":"Chitturi","year":"2020","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_192","first-page":"9943937","article-title":"COVID-19 Induced Cardiomyopathy Successfully Treated with Tocilizumab","volume":"2022","author":"Schreiber","year":"2022","journal-title":"Case Rep. Cardiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/jmv.25964","article-title":"Tocilizumab for the treatment of severe coronavirus disease 2019","volume":"92","author":"Alattar","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_194","unstructured":"National Institutes of Health (2023, January 25). COVID-19 Treatment Guidelines, Available online: https:\/\/www.covid19treatmentguidelines.nih.gov\/therapies\/."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(21)00438-4","article-title":"Current and future status of JAK inhibitors","volume":"398","author":"McLornan","year":"2021","journal-title":"Lancet"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/eji.202149173","article-title":"Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection","volume":"51","author":"Solimani","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"738687","DOI":"10.3389\/fmed.2021.738687","article-title":"Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses","volume":"8","author":"Baranova","year":"2021","journal-title":"Front. Med."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Dieter, C., de Almeida Brondani, L., Lemos, N.E., Schaeffer, A.F., Zanotto, C., Ramos, D.T., Girardi, E., Pellenz, F.M., Camargo, J.L., and Moresco, K.S. (2022). Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19. Genes, 14.","DOI":"10.3390\/genes14010029"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Clohisey","year":"2021","journal-title":"Nature"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group (2022). Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet, 400, 359\u2013368.","DOI":"10.1101\/2022.03.02.22271623"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2213-2600(22)00006-6","article-title":"Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: An exploratory, randomised, placebo-controlled trial","volume":"10","author":"Ely","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/art.40841","article-title":"Cardiovascular Safety During Treatment with Baricitinib in Rheumatoid Arthritis","volume":"71","author":"Taylor","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in Patients Hospitalized with COVID-19 Pneumonia","volume":"385","author":"Guimaraes","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/art.40911","article-title":"Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients with Rheumatoid Arthritis","volume":"71","author":"DeMasi","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.semarthrit.2016.05.014","article-title":"Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor","volume":"46","author":"Wicker","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00296-017-3844-9","article-title":"Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: A cohort study","volume":"37","author":"Kume","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.121.319060","article-title":"An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts","volume":"129","author":"Yang","year":"2021","journal-title":"Circ. Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: A retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: A cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: A double-blind, randomized controlled phase 3 trial","volume":"27","author":"Kyriazopoulou","year":"2021","journal-title":"Nat. Med."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"The CORIMUNO-19 Collaborative Group, Tharaux, P.-L., Pialoux, G., Pavot, A., Mariette, X., Hermine, O., Resche-Rigon, M., Porcher, R., Ravaud, P., and Bureau, S. (2021). Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): A randomised controlled trial. Lancet Respir. Med., 9, 295\u2013304.","DOI":"10.1016\/S2213-2600(20)30556-7"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cjco.2020.10.003","article-title":"Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient with COVID-19 Myocarditis","volume":"3","author":"Trpkov","year":"2021","journal-title":"CJC Open"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jama.2021.9508","article-title":"Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized with Severe COVID-19: A Randomized Clinical Trial","volume":"326","author":"Caricchio","year":"2021","journal-title":"JAMA"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra Therapy for Non-cancer Inflammatory Diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of COVID-19\u2014Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 Days in Patients with Severe COVID-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19: A Randomized Clinical Trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early Remdesivir to Prevent Progression to Severe COVID-19 in Outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Rafaniello, C., Ferrajolo, C., Sullo, M.G., Gaio, M., Zinzi, A., Scavone, C., Gargano, F., Coscioni, E., Rossi, F., and Capuano, A. (2021). Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System. Pharmaceuticals, 14.","DOI":"10.3390\/ph14070611"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12012-021-09703-9","article-title":"Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review","volume":"22","author":"Nabati","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_225","first-page":"e11132","article-title":"Cardiac Adverse Events with Remdesivir in COVID-19 Infection","volume":"12","author":"Gupta","year":"2020","journal-title":"Cureus"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijid.2021.09.036","article-title":"Safety and heart rate changes in COVID-19 patients treated with Remdesivir","volume":"112","author":"Brunetti","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"104955","DOI":"10.1016\/j.antiviral.2020.104955","article-title":"Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes","volume":"184","author":"Choi","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with COVID-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cpt.2646","article-title":"Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir\/Ritonavir (Paxlovid) and Comedications","volume":"112","author":"Marzolini","year":"2022","journal-title":"Clin. Pharm. Ther."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Nappi, F., Iervolino, A., and Avtaar Singh, S.S. (2022). Molecular Insights of SARS-CoV-2 Antivirals Administration: A Balance between Safety Profiles and Impact on Cardiovascular Phenotypes. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020437"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for Oral Treatment of COVID-19 in Nonhospitalized Patients","volume":"386","author":"Musungaie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","article-title":"Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong\u2019s omicron BA.2 wave: A retrospective cohort study","volume":"22","author":"Wong","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"eabl7430","DOI":"10.1126\/scitranslmed.abl7430","article-title":"A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus","volume":"14","author":"Fischer","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Gentile, I., Scotto, R., Schiano Moriello, N., Pinchera, B., Villari, R., Trucillo, E., Ametrano, L., Fusco, L., Castaldo, G., and Buonomo, A.R. (2022). Nirmatrelvir\/Ritonavir and Molnupiravir in the Treatment of Mild\/Moderate COVID-19: Results of a Real-Life Study. Vaccines, 10.","DOI":"10.1101\/2022.08.23.22278585"},{"key":"ref_235","first-page":"e31508","article-title":"Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India","volume":"14","author":"Sinha","year":"2022","journal-title":"Cureus"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis","volume":"54","author":"Wen","year":"2022","journal-title":"Ann. Med."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.amjcard.2009.12.059","article-title":"Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study)","volume":"105","author":"Abbate","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"e014941","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients with ST-Segment-Elevation Myocardial Infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","article-title":"Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]","volume":"111","author":"Abbate","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)","volume":"113","author":"Arena","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"e004373","DOI":"10.1161\/CIRCHEARTFAILURE.117.004373","article-title":"Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)","volume":"10","author":"Canada","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"e005036","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 Blockade in Patients with Heart Failure with Preserved Ejection Fraction","volume":"11","author":"Trankle","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of Anakinra on Recurrent Pericarditis Among Patients with Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/508\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:32:02Z","timestamp":1760121122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":243,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["v15020508"],"URL":"https:\/\/doi.org\/10.3390\/v15020508","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]}}}